STOCK OPTION AGREEMENTStock Option Agreement • January 3rd, 2018 • Biolargo, Inc. • Chemicals & allied products • Delaware
Contract Type FiledJanuary 3rd, 2018 Company Industry JurisdictionThis Non-Qualified Stock Option Agreement (this “Agreement”) is made and entered into as of December 31, 2017 (the “Grant Date”) by and between BioLargo, Inc., a Delaware corporation (the “Company”), and Charles K. Dargan II, an individual (“Optionee”). Capitalized terms used herein without definition shall have the meanings given to them in Appendix “A” attached hereto and incorporated herein by this reference).
STOCK OPTION AGREEMENTStock Option Agreement • May 4th, 2017 • Biolargo, Inc. • Chemicals & allied products • Delaware
Contract Type FiledMay 4th, 2017 Company Industry JurisdictionThis Non-Qualified Stock Option Agreement (this “Agreement”) is made and entered into as of May 2, 2017 (the “Grant Date”) by and between BioLargo, Inc., a Delaware corporation (the “Company”), and Dennis P. Calvert, an individual (“Optionee”). Capitalized terms used herein without definition shall have the meanings given to them in Appendix “A” attached hereto and incorporated herein by this reference).
STOCK OPTION AGREEMENTStock Option Agreement • February 14th, 2017 • Biolargo, Inc. • Chemicals & allied products • Delaware
Contract Type FiledFebruary 14th, 2017 Company Industry JurisdictionThis Non-Qualified Stock Option Agreement (this “Agreement”) is made and entered into as of February 10, 2017 (the “Grant Date”) by and between BioLargo, Inc., a Delaware corporation (the “Company”), and Charles K. Dargan II, an individual (“Optionee”). Capitalized terms used herein without definition shall have the meanings given to them in Appendix “A” attached hereto and incorporated herein by this reference).
STOCK OPTION AGREEMENTStock Option Agreement • March 31st, 2015 • Biolargo, Inc. • Chemicals & allied products • Delaware
Contract Type FiledMarch 31st, 2015 Company Industry JurisdictionThis Non-Qualified Stock Option Agreement (this “Agreement”) is made and entered into as of _________ (the “Grant Date”) by and between BioLargo, Inc., a Delaware corporation (the “Company”), whose address is 3500 W. Garry Ave, Santa Ana, California 92704, and _________________, an individual (“Optionee”). Capitalized terms used herein without definition shall have the meanings given to them in Appendix “A” attached hereto and incorporated herein by this reference).